In Brief: VIMRx Pharmaceuticals
Executive Summary
VIMRx Pharmaceuticals: Former DuPont Merck Exec VP Richard Dunning to president and CEO of Stamford, Conn.-based biotech. A group of investors led by MacAndrews & Forbes Holdings Chairman Ronald Perelman has agreed to purchase $4.2 mil. of VIMRx equity securities, consisting of approximately 2.8 mil. shares of common stock and 1.4 mil. warrants...